During the past decade, Hospital Dr. Nélio Mendonça conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Dr. Nélio Mendonça" are "COVID-19" (1 trials), "Diabetic Nephropathies" (1 trials), "Hospital Mortality" (1 trials) and "Relapsing Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Hospital Dr. Nélio Mendonça" in a lesser frequency.

Most popular intervention types in "Hospital Dr. Nélio Mendonça" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "BI 690517" (1 trials), "Eplerenone" (1 trials), "Placebo" (1 trials), "RDV Placebo" (1 trials) and "Remdesivir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Dr. Nélio Mendonça" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Dr. Nélio Mendonça". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Dr. Nélio Mendonça, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Dr. Nélio Mendonça, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".